NewYork-Presbyterian Hospital:企業の戦略的SWOT分析

◆英語タイトル:NewYork-Presbyterian Hospital - Strategic SWOT Analysis Review
◆商品コード:DATA904C12708
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:36
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:政府系・NPO
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

NewYork-Presbyterian Hospital – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

NewYork- Presbyterian Hospital (NYPH) is a not-for-profit medical center, providing a wide range of health care services to the residents of the New York. It operates through a network of hospitals and medical centers. Its service portfolio includes a wide range of medical, surgical, and emergency care services in the therapeutic areas of cancer, children’s health, geriatrics, heart, orthopedics, neuroscience, psychiatry, transplantation and women’s health, among others. The hospital also offers clinical and medical research, medical education and community services in affiliation with two medical colleges, namely, Weill Cornell Medical College and Columbia University College of Physicians and Surgeons. The hospital was formed as a result of the merger between The New York Hospital and The Presbyterian Hospital. NYPH is headquartered in New York, the US.

NewYork-Presbyterian Hospital Key Recent Developments

May 10,2018: Dr. Katherine L. Heilpern Named Senior Vice President and Chief Operating Officer at NewYork-Presbyterian/Weill Cornell Medical Center
Apr 24,2018: NewYork-Presbyterian Opens A World-Class Center For Ambulatory Care: NewYork-Presbyterian David H. Koch Center
Dec 07,2017: Study Shows Acupuncture Decreased Joint Pain in Breast Cancer Patients Treated with Aromatase Inhibitors
Nov 16,2017: Irving Family’s $700 Million Bequest to Columbia University and NewYork-Presbyterian Sets Stage for Dramatic Advances in Cancer Research and Care
Aug 02,2017: Dr. Laureen Hill named senior vice president and chief operating officer

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
Section 1 – About the Company 5
NewYork-Presbyterian Hospital – Key Facts 5
NewYork-Presbyterian Hospital – Key Employees 6
NewYork-Presbyterian Hospital – Key Employee Biographies 9
NewYork-Presbyterian Hospital – Major Products and Services 12
NewYork-Presbyterian Hospital – History 13
NewYork-Presbyterian Hospital – Company Statement 17
NewYork-Presbyterian Hospital – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Section 2 – Company Analysis 20
Company Overview 20
NewYork-Presbyterian Hospital – Business Description 21
R&D Overview 21
NewYork-Presbyterian Hospital – Corporate Strategy 22
NewYork-Presbyterian Hospital – SWOT Analysis 23
SWOT Analysis – Overview 23
NewYork-Presbyterian Hospital – Strengths 23
NewYork-Presbyterian Hospital – Weaknesses 24
NewYork-Presbyterian Hospital – Opportunities 25
NewYork-Presbyterian Hospital – Threats 26
NewYork-Presbyterian Hospital – Key Competitors 27
NewYork-Presbyterian Hospital, Recent Deals Summary 28
Section 3 – Company’s Recent Developments 29
May 10, 2018: Dr. Katherine L. Heilpern Named Senior Vice President and Chief Operating Officer at NewYork-Presbyterian/Weill Cornell Medical Center 29
Apr 24, 2018: NewYork-Presbyterian Opens A World-Class Center For Ambulatory Care: NewYork-Presbyterian David H. Koch Center 31
Dec 07, 2017: Study Shows Acupuncture Decreased Joint Pain in Breast Cancer Patients Treated with Aromatase Inhibitors 33
Nov 16, 2017: Irving Family’s $700 Million Bequest to Columbia University and NewYork-Presbyterian Sets Stage for Dramatic Advances in Cancer Research and Care 35
Section 4 – Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36

List of Tables
NewYork-Presbyterian Hospital, Key Facts 5
NewYork-Presbyterian Hospital, Key Employees 6
NewYork-Presbyterian Hospital, Key Employee Biographies 9
NewYork-Presbyterian Hospital, Major Products and Services 12
NewYork-Presbyterian Hospital, History 13
NewYork-Presbyterian Hospital, Other Locations 18
NewYork-Presbyterian Hospital, Subsidiaries 19
NewYork-Presbyterian Hospital, Key Competitors 27
NewYork-Presbyterian Hospital, Recent Deals Summary 28

★海外企業調査レポート[NewYork-Presbyterian Hospital:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Metalfrio Solutions SA:企業の戦略・SWOT・財務情報
    Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report Summary Metalfrio Solutions SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Acciona SA (ANA):電力:M&Aディール及び事業提携情報
    Summary Acciona SA (Acciona) is a provider of sustainable solutions for infrastructure and renewable energy projects. The company develops and manages infrastructure, renewable energy, water, and other facilities. Its operations cover the whole value chain, from design and construction to operation …
  • Oceania Cruises, Inc.:企業の戦略・SWOT・財務分析
    Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oceania Cruises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Calithera Biosciences Inc (CALA):企業の財務・戦略的SWOT分析
    Summary Calithera Biosciences Inc (Calithera) is a clinical-stage bio-pharmaceutical company that discovers and develops novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer . The company’s product pipeline includes CB-839, a glutamina …
  • MSL Solutions Limited (MPW):企業の財務・戦略的SWOT分析
    MSL Solutions Limited (MPW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • OSRAM Licht AG:企業のM&A・事業提携・投資動向
    OSRAM Licht AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's OSRAM Licht AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestmen …
  • Futuren (FTRN):企業の財務・戦略的SWOT分析
    Futuren (FTRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • ID Pharma Co Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary ID Pharma Co Ltd (ID Pharma), formerly DNAVEC Corp is a manufacturer and commercializer of gene medicines. The company develops regenerative medicines, cell therapy and other bio products. It provides vector platforms such as Sendai virus vector in its drug development process. ID Pharma’s v …
  • Pentair Plc (PNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Pentair Plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water treatment systems and high-performance products and solutions for filtration, separation and fluid process management. Its product portfolio includes point-of-entry and point-of-use filtr …
  • Asatsu-DK Inc.:企業の戦略的SWOT分析
    Asatsu-DK Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Spineway SAS (ALSPW):企業の財務・戦略的SWOT分析
    Summary Spineway SAS (Spineway) is a medical device company that manufactures, designs, and commercializes surgical implants and instruments. The company offers products such as thoraco-lumbar, cervical, mini invasive products and other bio materials. Its thoraco-lumbar products include mont blanc d …
  • Shenzhen Kaifa Technology Co Ltd (000021):企業の財務・戦略的SWOT分析
    Shenzhen Kaifa Technology Co Ltd (000021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Tocardo International BV:電力:M&Aディール及び事業提携情報
    Summary Tocardo International BV (Torcado), a subsidiary of Tribute Resources Inc, is an energy equipment provider that manufactures and markets offshore turbines. The company offers wind turbines, sea defences, commercial demonstrator and others. It also offers river and tidal turbines. Torcado’s p …
  • Tribune Media Company:戦略・SWOT・企業財務分析
    Tribune Media Company - Strategy, SWOT and Corporate Finance Report Summary Tribune Media Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Matrai Eromu ZRt:企業の戦略的SWOT分析
    Matrai Eromu ZRt - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Kedrion SpA-製薬・医療分野:企業M&A・提携分析
    Summary Kedrion SpA (Kedrion) collects and fractionates blood plasma to develop, produce and distribute plasma-derived therapies. The company’s products are used for the treatment of rare and serious disorders such as hemophilia, immune deficiency and neurological disorders. It also offers products …
  • Movado Group, Inc. (MOV):企業の財務・戦略的SWOT分析
    Movado Group, Inc. (MOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Severoceske doly as:企業の戦略・SWOT・財務情報
    Severoceske doly as - Strategy, SWOT and Corporate Finance Report Summary Severoceske doly as - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Innate Pharma SA (IPH):企業の財務・戦略的SWOT分析
    Summary Innate Pharma SA (Innate Pharma) is a biotechnology company developing antibodies to treat cancer by harnessing the immune system. It offers Lumoxiti, a CD22-directed immunotoxin for the treatment of relapsed or refractory hairy cell leukemia (HCL). The company is investigating drugs against …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196):企業の財務・戦略的SWOT分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆